RSS feed

Publications by Anne-Birgitte Jacobsen

25 publications found

Original articles

Lorntzsen B, Jacobsen AB, GrØholt KK, Sigstad E, Osnes T (2020)
Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment
Anticancer Res, 40 (12), 6979-6985
DOI 10.21873/anticanres.14722, PubMed 33288592

von Döbeln GA, Wagenius G, Holtved E, Jacobsen AB, Nilsson M, Yu J, Baeksgaard L (2020)
Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction
Cancer Treat Res Commun, 24, 100187
DOI 10.1016/j.ctarc.2020.100187, PubMed 32619832

Sunde B, Klevebro F, Johar A, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Ajengui A, Lundell L, Lagergren P, Nilsson M (2019)
Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial)
Br J Surg, 106 (11), 1452-1463
DOI 10.1002/bjs.11246, PubMed 31436322

von Döbeln GA, Klevebro F, Jacobsen AB, Johannessen HO, Nielsen NH, Johnsen G, Hatlevoll I, Glenjen NI, Friesland S, Lundell L, Yu J, Nilsson M (2019)
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
Dis Esophagus, 32 (2)
DOI 10.1093/dote/doy078, PubMed 30137281

Sunde B, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Rouvelas I, Wang N, Lundell L, Lagergren P, Nilsson M (2019)
Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
Dis Esophagus, 32 (2)
DOI 10.1093/dote/doy069, PubMed 30084992

Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E (2017)
Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery
Eur Arch Otorhinolaryngol, 274 (12), 4203-4209
DOI 10.1007/s00405-017-4764-8, PubMed 29019001

Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
Improved treatment decisions in patients with esophageal cancer
Acta Oncol, 56 (10), 1286-1294
DOI 10.1080/0284186X.2017.1346379, PubMed 28686501

Klevebro F, Alexandersson von Döbeln G, Wang N, Johnsen G, Jacobsen AB, Friesland S, Hatlevoll I, Glenjen NI, Lind P, Tsai JA, Lundell L, Nilsson M (2016)
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
Ann Oncol, 27 (4), 660-7
DOI 10.1093/annonc/mdw010, PubMed 26782957

Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M (2015)
Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
Eur J Surg Oncol, 41 (7), 920-6
DOI 10.1016/j.ejso.2015.03.226, PubMed 25908010

Amdal CD, Jacobsen AB, Sandstad B, Warloe T, Bjordal K (2013)
Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
Radiother Oncol, 107 (3), 428-33
DOI 10.1016/j.radonc.2013.04.008, PubMed 23647761

Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
Acta Oncol, 50 (7), 1068-74
DOI 10.3109/0284186X.2011.585998, PubMed 21745131

Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Sandstad B, Bjordal K (2011)
Palliative interventions and prognosis in patients with advanced esophageal cancer
Dis Esophagus, 24 (7), 502-9
DOI 10.1111/j.1442-2050.2010.01174.x, PubMed 21309923

Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Karlsen KO, Sandstad B, Bjordal K (2010)
Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital
Acta Oncol, 49 (2), 209-18
DOI 10.3109/02841860903246573, PubMed 19929566

Gunnes N, Seierstad TG, Aamdal S, Brunsvig PF, Jacobsen AB, Sundstrøm S, Aalen OO (2009)
Assessing quality of life in a randomized clinical trial: correcting for missing data
BMC Med Res Methodol, 9, 28
DOI 10.1186/1471-2288-9-28, PubMed 19405936

Oldervoll LM, Loge JH, Kaasa S, Lydersen S, Hjermstad MJ, Thorsen L, Holte H, Jacobsen AB, Fosså SD (2007)
Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study
BMC Cancer, 7, 210
DOI 10.1186/1471-2407-7-210, PubMed 17997822

Fjøsne HE, Jacobsen AB, Lundgren S, Norwegian Breast Cancer Group (NBCG) (2007)
Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up
Eur J Surg Oncol, 34 (1), 6-12
DOI 10.1016/j.ejso.2007.07.002, PubMed 17881183

Jacobsen AB, Pettersen EO, Amellem O, Berner A, Ous S, Fosså SD (1992)
The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy
J Urol, 147 (1), 34-7
DOI 10.1016/s0022-5347(17)37127-6, PubMed 1729547

Jacobsen AB, Berner A, Juul M, Ous S, Pettersen EO, Fosså SD (1992)
DNA flow cytometry and neo-adjuvant chemotherapy/radiotherapy in operable muscle-invasive bladder carcinoma. A preliminary report
Eur Urol, 22 (4), 316-22
DOI 10.1159/000474779, PubMed 1490510

Jacobsen AB, Tveit KM, Pettersen EO, Fossa SD, Ous S (1991)
Colony formation in urinary bladder carcinoma. Relationship to DNA flow cytometry, stage and histopathology
Anticancer Res, 11 (2), 777-81
PubMed 2064333

Jacobsen AB, Nesland JM, Fosså SD, Pettersen EO (1990)
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma
J Urol, 143 (4), 706-9
DOI 10.1016/s0022-5347(17)40066-8, PubMed 2313795

Jacobsen AB, Lunde S, Ous S, Melvik JE, Pettersen EO, Kaalhus O, Fosså SD (1989)
T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values
Int J Radiat Oncol Biol Phys, 17 (5), 923-9
DOI 10.1016/0360-3016(89)90137-5, PubMed 2808053

Jacobsen AB, Thorud E, Fosså SD, Lunde S, Shoaib MC, Juul NO, Pettersen EO (1988)
DNA flow cytometry in metastases and a recurrency of malignant melanomas. A comparison of results from fresh and paraffin embedded material
Virchows Arch B Cell Pathol Incl Mol Pathol, 54 (5), 273-7
DOI 10.1007/BF02899223, PubMed 2895539

Jacobsen AB, Fosså SD, Thorud E, Lunde S, Melvik JE, Pettersen EO (1988)
DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material
APMIS, 96 (1), 25-9
DOI 10.1111/j.1699-0463.1988.tb05263.x, PubMed 3278720

Jacobsen AB, Fosså SD, Lunde S, Melvik JE, Pettersen EO (1987)
Flow cytometric DNA measurements in paraffin-embedded bladder carcinoma tissue before and after precystectomy radiotherapy
Radiother Oncol, 10 (2), 149-55
DOI 10.1016/s0167-8140(87)80057-9, PubMed 3423304

Review articles

Amdal CD, Jacobsen AB, Guren MG, Bjordal K (2012)
Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
Acta Oncol, 52 (4), 679-90
DOI 10.3109/0284186X.2012.731521, PubMed 23190360